FDA Drug Application (206041) for ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number206041
Product Number001
FormTABLET;ORAL
Dosage300MG;100MG;150MG;300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
Active IngredientATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient ATAZANAVIR SULFATE6
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient RITONAVIR11
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by MYLAN LABS LTD